A Tetris-like game played after recalling trauma cuts flashbacks by 90%, offering a simple, scalable PTSD tool.

Novo Nordisk's stock dropped to a five-year low after its weight-loss drug underperformed Eli Lilly’s, despite strong financials.

FDA approves new oral combo for untreated CLL, showing better outcomes than chemo.

India’s pharma exports hit $30.5B in 2024–25, with goals to reach $130B by 2030.

GSK to buy Canada’s 35Pharma for $950M to develop HS235, an experimental drug for pulmonary hypertension.

UAE ends drug monopolies, requiring multiple agents per medicine to boost competition and supply stability.

Eris and Natco to launch generic semaglutide in India in March 2026 post-patent expiry.

Pfizer gains rights to sell ecnoglutide in China, a diabetes and obesity drug approved in January 2026.

AbbVie to invest $380M in two new North Chicago plants for neuroscience and obesity drugs, launching in 2029 with 300 new jobs.

Microplastics found in most prostate tumors and nearby tissue, raising concerns about a possible link to cancer.